Basic and Diluted Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Basic and Diluted Loss Per Share [Abstract]

Schedule of Diluted Loss Per Share

The basic and diluted net loss per share and weighted average number of shares of Common Stock used in the calculation of basic and diluted net loss per share are as follows:

		Three Months Ended March 31,
		2026				*2025 ()**
Basic and dilutedloss per share of common stock
Numerator:
Net loss			19,140				7,659
Preferred dividends on Series Y Convertible Preferred Stock			85				-
Numerator			19,225				7,659
Denominator:
Number of shares of common stock outstanding			2,357,591				1,093,177
Number of shares upon pre-funded warrants and A&R Warrants exercise			246,216				122,760
Number of shares upon Fully vested Warrants exercise			-				16
Total weighted-average number of shares of common stock, shares upon pre-funded warrants, A&R Warrants and Fully vested Warrants exercise used in computing basic and diluted loss per share			2,603,807				1,215,953
Basic and diluted loss per share of common stock			7.38				6.27

Schedule of Diluted Loss Per Share Effect of Anti-Dilutive

The calculation of diluted loss per share for the three months ended March 31, 2026 and March 31, 2025, does not include the shares underlying the following financial instruments because their effect would be anti-dilutive:

		Three Months Ended March 31,
		2026				2025

Options			41,096				101,246	(*)
Warrants			959,704				959,704	(*)
Contingent shares			10,526				10,526	(*)
Redeemable Convertible Preferred Shares			776,383				777,553	(*)

(*)	All share amounts have been retroactively adjusted to reflect a 1-for-19 reverse share split as discussed in Note 7A.